Swiss generic-drug maker Sandoz Group AG sharply criticized a recent appeal by Europe’s pharmaceutical industry urging the European Union to increase drug prices as a way to counter the threat of US ...

† College of Pharmacy, CHA University, Pocheon 487-010, Republic of Korea ‡ College of Pharmacy, Wonkwang University, Iksan 570-749, Republic of Korea Article Views are the COUNTER-compliant sum of ...

SpyGlass Pharma's drug delivery platform aims for long-term glaucoma management, delivering 3 years of bimatoprost to lower intraocular pressure. The $75 million Series D funding will support phase 3 ...

June 02, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a privately held ophthalmic biotechnology company, today announced the closing of a $75 million Series D financing round. SpyGlass’ Drug ...

[Image from the SpyGlass Pharma website] SpyGlass Pharma announced today that it closed a $75 million Series D financing round to support its drug delivery platform. Sands Capital led the financing ...

June 02, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a privately held ophthalmic biotechnology company, today announced the closing of a $75 million Series D financing round. SpyGlass’ Drug ...

At a pre-planned analysis, zilovertamab vedotin 1.75 mg/kg in combination with R-GemOx achieved a 56.3% objective response rate (ORR) in patients with relapsed or refractory DLBCL (n=16), with eight ...

I am eager to be a part of these exciting times at Sandoz —supporting our evolution as a standalone organization, enabling future-ready capabilities, and helping bring our People & Organization ...

Vituity workers received initial court approval for their $8.75 million class settlement in a lawsuit accusing the California-based health-care company of mismanaging their 401(k) plan through high ...